COMPANY PROFILE

Matinas BioPharma

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections

Tarpon Springs, United StatesFounded 2011Biotech & Life Sciences

Valuation $1.7M Market cap · 2026

About Matinas BioPharma

Matinas BioPharma is a biopharmaceutical company focused on developing innovative therapies for cardiovascular and infectious diseases. The company operates in the healthcare sector, targeting patients with elevated triglyceride levels and those requiring advanced drug delivery solutions. Matinas BioPharma's core products include MAT9001, a novel omega-3 fatty acid composition aimed at treating high triglyceride levels, and MAT2203 and MAT2501, which leverage their proprietary Lipid Nano-Crystal (LNC) platform to improve the delivery of various therapeutics, including antifungal and antibacterial treatments. The LNC platform allows for safe, intracellular, and even orally administered delivery of a broad range of drug therapies, enhancing the efficacy and safety of treatments. Matinas BioPharma generates revenue through the development and potential commercialization of its proprietary drug candidates, targeting both the cardiovascular and infectious disease markets. The company serves healthcare providers, patients, and potentially pharmaceutical partners seeking advanced drug delivery technologies.

MoreLess Source: Dealroom company data

At a glance

Status: Listed
Founded: 2011
Headquarters: Tarpon Springs, United States
Listing: IPO 2014
Sector: Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

SVSternAegis Ventures

Talent

Book a demo to see the people

Team profiled 10 named & role-tagged

Founders /100 quality score

Key operators 4 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Matinas BioPharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Matinas BioPharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles